Lindus Health · Series B
The anti-CRO running radically faster, AI-enabled clinical trials end to end
Amount
$55M
Round
Series B
Valuation
—
Announced
—
Investors
Participating investors
The anti-CRO running radically faster, AI-enabled clinical trials end to end
Amount
$55M
Round
Series B
Valuation
—
Announced
—
Participating investors